Harte Hanks, Inc. (Nasdaq: HHS) closed at $4.18 on October 20, 2026, against a $5.00-a-share takeover by Star Equity Holdings, Inc. (Nasdaq: STRR). Value investor Calvin Blissett says he bought at $4.20 for a "19% gross spread," but half of the deal is paid in a Star preferred stock that traded only about 4,300 shares a day over the last 30 sessions. The S-4 filed October 19 is not yet effective and still points to a fourth-quarter 2026 close.
This is journalism and commentary, not investment advice. We hold no position unless stated.
Key facts
- Ticker and exchange: Harte Hanks, Inc., HHS, Nasdaq. Buyer: Star Equity Holdings (STRR); preferred: STRRP.
- Situation type: micro-cap merger arbitrage paid in cash and preferred stock.
- The call: Calvin Blissett (@calvinblissett) posted on October 20, 2026 that he bought HHS at $4.20; the prior close was $4.36.
- Deal terms: $5.00 cash or 0.50 STRRP preferred per share, with total cash capped at $19.2 million, about half of the $38.4 million equity value (August 14, 2026 release).
- Rival bid: an unnamed "Party A" raised its all-cash proposal to $4.60 on September 11, 2026 and was still talking as of October 19.
- Preferred liquidity: STRRP closed at $9.10 on October 20, 2026, against a $10.00 liquidation preference; 2,455,000 shares were outstanding at June 30, 2026.
- Timing: outside date March 1, 2027; no meeting date set as of October 19, 2026.
Is HHS a good bet right now?
The arithmetic depends on how the preferred is valued. Mr. Blissett's 19% uses the $5.00 headline against $4.20. At STRRP's $9.10 close, the 0.50-share preferred leg is worth about $4.55, so a 50/50 mix is worth about $4.78 a share, a spread of about 14% over $4.18, by our math.
That is wide for a signed deal. The deal is small, the buyer needs debt financing, and holders who get preferred may struggle to sell it.
Why are investors bullish on Harte Hanks?
- A signed deal at a big premium. The $5.00 price was 119% above the $2.28 close on August 7, 2026, per the S-4.
- Financing support. On August 13, 2026, the deal's lender sent Harte Hanks a letter confirming its confidence to provide up to $15 million, the minimum the deal requires.
- A second bidder. Party A's $4.60 all-cash proposal is 10% above the October 20 close.
- Insider support. Directors, including 5.7% holder Bradley Radoff, signed voting agreements.
- A 10% coupon. Star declared $0.50 a share of STRRP dividends in the first half of 2026, per its Q2 10-Q.
Who's making this call and why?
Calvin Blissett is a value investor with about 10,700 followers on X who publishes write-ups on Substack. On October 20 he laid out the case: the S-4 is filed, the bank letter covers the $15 million needed, the Q4 2026 close was reaffirmed, and Party A sits at $4.60. His summary: "19% gross spread, 76% IRR." The IRR is his estimate and assumes an on-time close.
He also named the main risk. Asked about the mix, he replied that he would buy STRRP from forced sellers, adding: "It may get dumped since the amount being issued is a lot relative to current liquidity and this is a key risk."
Track record. Calvin Blissett is not yet scored on our scoreboard.
Other supporters: we found no other credible X account making a recent case on Harte Hanks. The board's backing and the Party A bid are the main outside support.
What's the bear case for HHS?
- Preferred overhang. At a 50/50 split, about 1.9 million new STRRP shares would be issued, about 78% of the shares outstanding at June 30, by our math. Average volume over the last 30 sessions was about 4,300 shares a day, per Yahoo Finance data.
- The preferred has already slipped, from $10.14 on August 13, 2026, before the deal, to $9.10 on October 20.
- Weak results. Harte Hanks lost $5.0 million in the second quarter of 2026 on $38.0 million of revenue, versus a $0.3 million loss a year earlier, per its Q2 10-Q.
- Financing condition. The deal needs at least $15.0 million of financing at closing; a letter of confidence is not funded money.
- Slipping timeline. The August 14 release targeted a close in 60 to 90 days. The S-4 came on day 66 and still needs SEC effectiveness.
Who disagrees?
We found no public bear on X. The skepticism sits in the filings:
- The buyer cut its own price. Star offered $5.50 on August 3, then lowered it to $5.00, citing about $4.5 million of transaction expenses, a $6 million swing in net debt, weaker second-quarter results and client-loss concerns.
- The $4.60 floor is softer than it looks. Party A's October 8 draft would cut its cash price dollar for dollar for bank debt repaid at closing, any cash shortfall and excess expenses.
- A large holder is waiting. A significant stockholder said on September 11 it would not discuss the deal before reviewing the proxy.
- The vote bar. Approval needs a majority of all outstanding shares, so shares that do not vote count against.
What are the key facts to verify?
- The S-4 background section for the Star price cut, Party A's bids and the lender letter.
- The September 15 go-shop update on the Exempted Party designations and the $1,152,000 termination fee.
What would prove it right or wrong?
Right: the S-4 goes effective, the vote passes, financing funds, and STRRP holds near $9 or better as new shares hit the market, or a higher all-cash bid arrives.
Wrong: financing slips past March 1, 2027, the vote fails, Harte Hanks loses more clients, or STRRP falls well below $9 as merger holders sell.
This is journalism and commentary, not investment advice. We hold no position unless stated.